LED BY PASSIONATE EXPERTS

Science That Scales.
Manufacturing That Delivers.

Integrated CRDMO services across discovery, development and commercial manufacturing for small molecules, peptides, lipids, oligos, high-potent APIs and large molecules.

Small Molecules

Expert synthesis and development of low-molecular-weight compounds, ranging from medicinal chemistry leads to complex high-potent APIs.

Discovery

Accelerating drug candidates through lead optimization, scaffold design, and comprehensive SAR studies to identify viable clinical molecules.

Clinical & Commercial

Scalable cGMP manufacturing providing end-to-end CMC support, process validation, and late-stage production for global market supply.

Large Molecules

Comprehensive development of biologics, including recombinant proteins, monoclonal antibodies, and enzymes using advanced microbial and mammalian platforms.

Discovery & Pre-clinical

Bridging research and development through cell line engineering, upstream optimization, and rigorous analytical characterization for safety and efficacy.

Clinical & Commercial

Integrated cGMP production with advanced purification, fill-finish capabilities, and regulatory support for large-scale therapeutic biologic manufacturing.

Built for Regulated Science.
Designed for Long-Term Partnerships.

At Anthem, every process is engineered for reproducibility, safety and regulatory confidence. Our teams work across disciplines — chemistry, analytics, engineering and compliance to ensure what begins in the lab performs at commercial scale.

85%

Programs Successfully Scaled from Development to Manufacturing

100%

Regulatory Inspection Readiness Track Record

Integrated Capabilities Across the Product Lifecycle

Anthem operates as an end-to-end CRDMO. Our development teams work alongside manufacturing, quality and regulatory experts from day one, reducing tech transfer risk and improving speed to scale.

FROM EARLY DISCOVERY AND DEVELOPMENT TO COMMERCIAL SUPPLY.
ONE INTEGRATED PLATFORM.

Anthem operates as a single, connected CDMO system. Our development teams work alongside manufacturing, quality and regulatory experts from day one — reducing tech transfer risk and improving speed to scale.

Specialty Ingredients

  • API's
  • Probiotics
  • Peptides
  • Biosimilars
  • Functional Enzymes
  • Nutritional Actives
  • Vitamin Analogues
  • Fermentation Products
  • Biotransformation Enzymes

Our Facilities

Unit I: Bommasandra

Established 2007 | 5 Acres | USFDA (2013, 2017, 2019, 2025) | ANVISA | PMDA

Unit II: Harohalli

Established 2016 | 15 Acres | USFDA (2023, 2024) | ANVISA | PMDA | TGA

Unit III: Neo Anthem

Established 2024 | 8 Acres | An Anthem Subsidiary